Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Digoxin specific antibody adverse reaction |
Causative agent |
False |
Digoxin specific antibody |
Inferred relationship |
Some |
|
Allergy to digoxin immune fab (finding) |
Causative agent |
False |
Digoxin specific antibody |
Inferred relationship |
Some |
|
Product containing digoxin immune fab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin specific antibody |
Inferred relationship |
Some |
|
digoxinspecifikt antistof 40 mg pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin specific antibody |
Inferred relationship |
Some |
|
digoxinspecifikt antistof 38 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin specific antibody |
Inferred relationship |
Some |
|
digoxinspecifikt antistof 40 mg pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin specific antibody |
Inferred relationship |
Some |
|